Online citations, reference lists, and bibliographies.
← Back to Search

Literature-based Recommendations For Treatment Planning And Execution In High-dose Radiotherapy For Lung Cancer.

S. Senan, D. de Ruysscher, P. Giraud, R. Mirimanoff, V. Budach
Published 2004 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND AND PURPOSE To review the literature on techniques used in high-dose radiotherapy of lung cancer in order to develop recommendations for clinical practice and for use in research protocols. PATIENTS AND METHODS A literature search was performed for articles and abstracts that were considered both clinically relevant and practical to use. The relevant information was arbitrarily categorized under the following headings: patient positioning, CT scanning, incorporating tumour mobility, definition of target volumes, radiotherapy planning, treatment delivery, and scoring of response and toxicity. RESULTS Recommendations were made for each of the above steps from the published literature. Although most of the recommended techniques have yet to be evaluated in multicenter clinical trials, their use in high-dose radiotherapy to the thorax appears to be rational on the basis of current evidence. CONCLUSIONS Recommendations for the clinical implementation of high-dose conformal radiotherapy for lung tumours were identified in the literature. Procedures that are still considered to be investigational were also highlighted.
This paper references
10.1016/S0959-8049(01)81265-X
Impact of intravenous contrast on target definition in radiotherapy of non small cell lung cancer
C. McGibney (2001)
10.1002/(SICI)1097-0142(19980201)82:3<433::AID-CNCR2>3.0.CO;2-Q
Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma
G. Sibley (1998)
10.1016/S0360-3016(01)01861-2
Can elective nodal irradiation be omitted in stage III non-small cell lung cancer? An analysis of recurrences after sequential chemotherapy and “involved-field” radiotherapy to 70 gy
S. Senan (2001)
10.1016/S0169-5002(00)80580-2
The location of recurrences in patients with non-small cell lungcancer treated with involved-field irradiation
P. Sørensen (2000)
10.1016/S0360-3016(98)00468-4
Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability.
J. Stroom (1999)
10.1016/S0360-3016(99)00095-4
Dose escalation of chart in non-small cell lung cancer: is three-dimensional conformal radiation therapy really necessary?
C. McGibney (1999)
10.1016/S0360-3016(97)00925-5
Electronic portal imaging with on-line correction of setup error in thoracic irradiation: clinical evaluation.
J. van de Steene (1998)
10.1016/S0360-3016(98)00489-1
Beam intensity modulation to reduce the field sizes for conformal irradiation of lung tumors: a dosimetric study.
M. Brugmans (1999)
10.1097/00004728-198807000-00001
Computed tomography of mediastinal lymph nodes in nonsmall cell lung cancer. A new approach based on the lymphatic pathway of tumor spread.
J. Buy (1988)
10.1016/0169-5002(94)93804-0
Loss of heterozygosity at chromosome 11P and tumour progression in non-small cell lung cancer
K. Fong (1994)
10.1016/S0169-5002(00)00214-2
An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer.
J. R. van Sörnsen de Koste (2001)
10.1088/0031-9155/48/1/304
Acquiring a four-dimensional computed tomography dataset using an external respiratory signal.
S. Vedam (2003)
10.1016/S0360-3016(01)02822-X
The effectiveness of breath-holding to stabilize lung and pancreas tumors during radiosurgery.
M. Murphy (2002)
10.1016/0169-5002(94)91873-2
International survey of radiotherapy practice for radical treatment of non-small cell lung cancer.
P. van Houtte (1994)
10.1016/S0360-3016(02)02853-5
What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer?
J. R. van Sörnsen de Koste (2002)
10.1016/S0360-3016(02)03238-8
Irradiated esophageal surface area predicts for esophagitis in patients treated for non-small cell carcinoma of the lung
J. Bradley (2002)
10.1016/0360-3016(95)02016-0
Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer.
M. Graham (1995)
10.1007/s00259-001-0710-4
PET-CT image co-registration in the thorax: influence of respiration
G. Goerres (2001)
10.1016/S0360-3016(01)01648-0
Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy.
Saeko Hirota (2001)
10.1016/S0009-9260(05)81130-4
The effect on apparent size of simulated pulmonary nodules of using three standard CT window settings.
K. M. Harris (1993)
10.1016/S0360-3016(00)80022-X
Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410)
R. Komaki (2000)
10.1016/S0360-3016(01)01716-3
Multiple "slow" CT scans for incorporating lung tumor mobility in radiotherapy planning.
F. Lagerwaard (2001)
10.1016/S0140-6736(97)06305-8
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial
M. Saunders (1997)
10.1007/s003300050990
Spiral CT of pulmonary nodules: interobserver variation in assessment of lesion size
D. Wormanns (2000)
10.1056/NEJM199901283400403
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide.
A. Turrisi (1999)
10.1016/S0167-8140(98)00026-7
Multiple two-dimensional versus three-dimensional PTV definition in treatment planning for conformal radiotherapy.
J. Stroom (1998)
10.1016/S0167-8140(01)00373-5
Dosimetric consequences of tumor mobility in radiotherapy of stage I non-small cell lung cancer--an analysis of data generated using 'slow' CT scans.
J. R. van Sörnsen de Koste (2001)
Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer.
H. Choy (1999)
10.1016/S1278-3218(00)80006-2
Systèmes d'immobilisation pour la radiothérapie conformationnelle du cancer bronchique non à petites cellules
R. Mirimanoff (2000)
10.1016/S0360-3016(01)01482-1
Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy.
K. Rosenzweig (2001)
10.1016/S0360-3016(00)00518-6
The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy.
M. V. van Herk (2000)
10.1016/0167-8140(93)90065-G
Feasibility of curative radiotherapy with a concomitant boost technique in 33 patients with non-small cell lung cancer (NSCLC)
A. Schuster-Uitterhoeve (1993)
10.1016/S0360-3016(02)04602-3
Are multiple CT scans required for planning curative radiotherapy in lung tumors of the lower lobe?
John R van Sörnsen de Koste (2003)
10.1200/JCO.2001.19.1.127
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial.
J. Hayman (2001)
10.1016/S0360-3016(01)01621-2
Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function.
C. Stevens (2001)
10.1148/RADIOLOGY.212.1.R99JL1956
Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax.
E. Patz (1999)
10.1016/S0167-8140(99)00143-7
Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.
S. Senan (1999)
10.1016/S0169-5002(02)00225-8
Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer (NSCLC)?
F. Lagerwaard (2002)
10.1016/S0360-3016(02)03807-5
Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.
K. Tsujino (2003)
10.1016/S0360-3016(02)03028-6
Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy.
S. Senan (2002)
10.1016/S0167-8140(01)00444-3
Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists.
P. Giraud (2002)
10.1016/S0360-3016(00)00750-1
Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning.
P. Giraud (2000)
10.1016/S0360-3016(01)01858-2
Preliminary results of a radiation therapy oncology group trial (RTOG 9311), a dose escalation study using 3d conformal radiation therapy in patients with inoperable nonsmall cell lung cancer
M. Graham (2001)
10.1016/S0360-3016(02)02803-1
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy.
Y. Seppenwoolde (2002)
10.2214/AJR.150.4.771
The number and size of normal mediastinal lymph nodes: a postmortem study.
K. Kiyono (1988)
10.2214/AJR.170.4.9530036
Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast-enhanced and unenhanced CT.
P. Cascade (1998)
10.1118/1.1531177
Respiration-correlated spiral CT: a method of measuring respiratory-induced anatomic motion for radiation treatment planning.
E. Ford (2003)
10.1016/S0360-3016(00)01579-0
CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers.
P. Giraud (2001)
10.1016/S0360-3016(00)00699-4
Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy.
M. Werner-wasik (2000)
10.1016/S0360-3016(99)00183-2
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
M. Graham (1999)
10.2214/AJR.144.2.261
Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping.
G. Glazer (1985)
10.1016/S0360-3016(01)02461-0
Interim analysis of a phase I/II dose escalation trial in non-small cell lung cancer (NSCLC) using three-dimensional conformal radiotherapy (3D-CRT)
J. Belderbos (2001)
10.1016/S0360-3016(00)00583-6
The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer.
K. Rosenzweig (2000)
10.1093/jnci/92.3.205
New Guidelines to Evaluate the Response to Treatment in Solid Tumors.
P. Therasse (2000)
10.1016/S0360-3016(02)04285-2
Procedures for high precision setup verification and correction of lung cancer patients using CT-simulation and digitally reconstructed radiographs (DRR).
J. R. van Sörnsen de Koste (2003)
10.1016/S0360-3016(98)00467-2
An analysis of anatomic landmark mobility and setup deviations in radiotherapy for lung cancer.
M. Samson (1999)
10.1148/RADIOLOGY.213.2.R99NV46530
Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.
B. Dwamena (1999)
10.1016/S0167-8140(00)00138-9
The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer
L. Vanuytsel (2000)
10.1016/S0360-3016(00)01413-9
Analysis and reduction of 3D systematic and random setup errors during the simulation and treatment of lung cancer patients with CT-based external beam radiotherapy dose planning.
H. D. de Boer (2001)
10.1016/0169-5002(94)91858-9
Induction therapy for stage III NSCLC: a consensus report.
M. Green (1994)
10.1016/S0936-6555(98)80106-4
An audit of 3D treatment planning facilities and practice in the UK.
S. McNee (1998)
10.1016/0360-3016(93)90289-8
Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer.
J. Armstrong (1993)
10.1378/CHEST.111.6.1718
Regional lymph node classification for lung cancer staging.
C. Mountain (1997)
10.1016/S0360-3016(02)03401-6
A method for the four-dimensional measurement of normal and cancerous lung during free breathing
Daniel A. Low (2002)
10.1016/S0360-3016(98)00196-5
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.
S. L. Kwa (1998)
10.1200/JCO.1999.17.9.2692
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
K. Furuse (1999)
10.1016/S0360-3016(01)01824-7
The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study.
K. Mah (2002)
10.1056/NEJM199202203260805
Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer.
C. Schaake-Koning (1992)
10.1378/CHEST.117.2.358
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer : Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
W. Sause (2000)
10.1016/S0360-3016(01)01766-7
Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing.
P. Giraud (2001)
10.1016/S0360-3016(96)00275-1
Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing.
J. Balter (1996)
10.1016/S0167-8140(02)00063-4
Stereotactic single high dose irradiation of lung tumors under respiratory gating.
R. Hara (2002)
10.1016/S0360-3016(98)00354-X
Setup reproducibility in radiation therapy for lung cancer: a comparison between T-bar and expanded foam immobilization devices.
R. Halperin (1999)
10.1016/S0360-3016(99)00163-7
Clinical and dosimetric predictors of radiation-induced esophageal toxicity.
P. D. Maguire (1999)
10.1016/S0360-3016(02)02958-9
High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.
J. Rosenman (2002)



This paper is referenced by
10.1177/030089160709300116
Role of Computed Tomographyand [18F] Fluorodeoxyglucose Positron Emission Tomography Image Fusion in Conformal Radiotherapy of Non-Small Cell Lung Cancer: A Comparison with Standard Techniques with and without Elective Nodal Irradiation
G. Ceresoli (2007)
10.1016/J.IJROBP.2007.08.071
Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer.
G. Bosmans (2008)
10.1016/j.lungcan.2008.07.008
Radiotherapy for lung cancer: clinical impact of recent technical advances.
C. Haasbeek (2009)
The Management of Respiratory Motion in Radiation Oncology Handout for AAPM 2005 Continuing Education Session, based on the
P. Keall (2005)
10.1016/J.SEMRADONC.2004.07.004
Defining target volumes for non-small cell lung carcinoma.
S. Senan (2004)
10.1016/J.SEMRADONC.2005.01.001
Target definition in the thorax and central nervous system.
P. Giraud (2005)
10.1007/s10269-016-2640-6
Radiothérapie et traitements combinés des cancers bronchiques non à petites cellules localement avancés
I. Martel-Lafay (2016)
10.1088/1361-6560/aae760
Implementation and evaluation of respiratory gating in small animal radiotherapy.
A-M Frelin (2018)
10.1118/1.3582692
Respiratory motion correction for quantitative PET/CT using all detected events with internal-external motion correlation.
Chi Liu (2011)
10.1016/j.ijrobp.2007.11.070
Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study.
A. V. van Baardwijk (2008)
10.1016/J.LUNGCAN.2006.12.011
Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey.
L. Kępka (2007)
10.1016/j.cpet.2008.09.001
FDG-PET Evaluation of Response to Treatment.
L. Kostakoglu (2008)
The optimization of image guided radiotherapy in lung cancer
R. Muirhead (2011)
10.1016/j.radonc.2013.07.015
Motion-specific internal target volumes for FDG-avid mediastinal and hilar lymph nodes.
J. Lamb (2013)
10.1016/j.radonc.2008.02.019
18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.
J. V. van Loon (2008)
[Assessment the efficacy of postoperative radiotherapy in the patients with non-small cell lung cancer. Retrospective study].
Elżbieta Chmielewska (2012)
10.1016/j.cllc.2012.03.007
Dose-escalation study of thoracic radiotherapy in combination with pemetrexed plus Cisplatin followed by pemetrexed consolidation therapy in Japanese patients with locally advanced nonsquamous non-small-cell lung cancer.
S. Niho (2013)
10.3933/JROI-1-1-3
Automated contrast painting for position verification in radiotherapy
Paul-Martin Putora (2009)
10.5306/wjco.v8.i1.1
Therapeutic management options for stage III non-small cell lung cancer
S. Yoon (2017)
10.1200/JCO.2011.38.4552
Pulmonary toxicity after bevacizumab and concurrent thoracic radiotherapy observed in a phase I study for inoperable stage III non-small-cell lung cancer.
J. S. Lind (2012)
10.1007/3-540-26632-1_8
Target Volumes in Non-Small Cell Lung Cancer
F. Lagerwaard (2005)
10.1097/01.coc.0000256691.27796.24
A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer
S. Yuan (2007)
10.1634/theoncologist.2007-0196
Modern radiotherapy as part of combined modality treatment in locally advanced non-small cell lung cancer: present status and future prospects.
J. Van Meerbeeck (2008)
Title Stereotactic ablative radiotherapy for medically inoperable earlystage lung cancer : early outcomes
A. Chan (2012)
10.1634/THEONCOLOGIST.2010-0150
Role of Postoperative Radiotherapy in Resected Non-Small Cell Lung Cancer: A Reassessment Based on New Data
C. L. Péchoux (2011)
10.1016/j.ijrobp.2010.01.050
Potentially curative radiotherapy for non-small-cell lung cancer in Norway: a population-based study of survival.
T. Strand (2011)
10.1118/1.2349696
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a).
P. Keall (2006)
Imaging tumour proliferation with [F-18]fluorothymidine PET in patients with non-small cell lung cancer in response to radiotherapy
I. Trigonis (2015)
de l'asservissement respiratoire dans la radioth erapie des cancers de l'oesophage
F. Lorchel (2007)
10.1016/S1877-1203(09)75254-1
Quels patients relèvent aujourd’hui de la radiothérapie ?
C. Hennequin (2009)
10.1007/978-3-642-36441-9_1
Introduction to 4D Motion Modeling and 4D Radiotherapy
Paul J. Keall (2013)
10.1016/j.radonc.2010.07.002
PET scans in radiotherapy planning of lung cancer.
D. D. De Ruysscher (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar